ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010

DCPC Board Defers Two Concepts More Approvals Listed

October 19, 1984

Other Concepts Approves By DCE Board Last Week

June 20, 1986

Radium Society To Meet In L.A.

March 2, 1979

Groups Urge Congress To Enact NIH Budget Increase; Encourage Individual Letters

November 3, 1995

NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets.

March 7, 2008